These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 12777275)

  • 1. Does cognitive recovery after treatment of poststroke depression last? A 2-year follow-up of cognitive function associated with poststroke depression.
    Narushima K; Chan KL; Kosier JT; Robinson RG
    Am J Psychiatry; 2003 Jun; 160(6):1157-62. PubMed ID: 12777275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cognitive impairment after poststroke depression : a double-blind treatment trial.
    Kimura M; Robinson RG; Kosier JT
    Stroke; 2000 Jul; 31(7):1482-6. PubMed ID: 10884441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved recovery in activities of daily living associated with remission of poststroke depression.
    Chemerinski E; Robinson RG; Kosier JT
    Stroke; 2001 Jan; 32(1):113-7. PubMed ID: 11136924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of milnacipran on cognitive dysfunction with post-stroke depression: preliminary open-label study.
    Sato S; Yamakawa Y; Terashima Y; Ohta H; Asada T
    Psychiatry Clin Neurosci; 2006 Oct; 60(5):584-9. PubMed ID: 16958942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does cognitive impairment cause post-stroke depression?
    Murata Y; Kimura M; Robinson RG
    Am J Geriatr Psychiatry; 2000; 8(4):310-7. PubMed ID: 11069271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment.
    Alvarez-Sabín J; Ortega G; Jacas C; Santamarina E; Maisterra O; Ribo M; Molina C; Quintana M; Román GC
    Cerebrovasc Dis; 2013; 35(2):146-54. PubMed ID: 23406981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal assessment of depression and cognitive impairment following stroke.
    Downhill JE; Robinson RG
    J Nerv Ment Dis; 1994 Aug; 182(8):425-31. PubMed ID: 8040651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for and correlates of poststroke depression following discontinuation of antidepressants.
    Fiedorowicz JG; Takezawa K; Robinson RG
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):399-405. PubMed ID: 18070842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-month Follow-up of Cognitive Impairment and Depressive Symptoms in Late-onset Depression.
    Wong MM; Chan CF; Li SW; Lau YM
    East Asian Arch Psychiatry; 2015 Dec; 25(4):146-9. PubMed ID: 26764288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment in remitted and non-remitted depressive patients: A follow-up comparison between first and recurrent episodes.
    Roca M; López-Navarro E; Monzón S; Vives M; García-Toro M; García-Campayo J; Harrison J; Gili M
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):1991-8. PubMed ID: 26293584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonlinguistic cognitive impairment in poststroke aphasia: a prospective study.
    El Hachioui H; Visch-Brink EG; Lingsma HF; van de Sandt-Koenderman MW; Dippel DW; Koudstaal PJ; Middelkoop HA
    Neurorehabil Neural Repair; 2014; 28(3):273-81. PubMed ID: 24213963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Barrow Neurological Institute screen for higher cerebral functions in cognitive screening after stroke.
    Redfors P; Hofgren C; Eriksson I; Holmegaard L; Samuelsson H; Jood K
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):349-55. PubMed ID: 23721621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertraline treatment of elderly patients with depression and cognitive impairment.
    Devanand DP; Pelton GH; Marston K; Camacho Y; Roose SP; Stern Y; Sackeim HA
    Int J Geriatr Psychiatry; 2003 Feb; 18(2):123-30. PubMed ID: 12571820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of depression at 3 and 15 months poststroke and their relationship with cognitive decline: the Sydney Stroke Study.
    Brodaty H; Withall A; Altendorf A; Sachdev PS
    Am J Geriatr Psychiatry; 2007 Jun; 15(6):477-86. PubMed ID: 17545448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NeuroAiD II (MLC901) in vascular cognitive impairment study (NEURITES).
    Chen CL; Ikram K; Anqi Q; Yin WT; Chen A; Venketasubramanian N;
    Cerebrovasc Dis; 2013; 35 Suppl 1():23-9. PubMed ID: 23548916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study.
    Jorge RE; Robinson RG; Tateno A; Narushima K; Acion L; Moser D; Arndt S; Chemerinski E
    Biol Psychiatry; 2004 Feb; 55(4):398-405. PubMed ID: 14960293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian sleep/wake rhythm abnormalities as a risk factor of a poststroke apathy.
    Cosin C; Sibon I; Poli M; Allard M; Debruxelles S; Renou P; Rouanet F; Mayo W
    Int J Stroke; 2015 Jul; 10(5):710-5. PubMed ID: 25545189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment issues in poststroke depression.
    Robinson RG
    Depress Anxiety; 1998; 8 Suppl 1():85-90. PubMed ID: 9809219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poststroke fatigue: risk factors and its effect on functional status and health-related quality of life.
    Chen YK; Qu JF; Xiao WM; Li WY; Weng HY; Li W; Liu YL; Luo GP; Fang XW; Ungvari GS; Xiang YT
    Int J Stroke; 2015 Jun; 10(4):506-12. PubMed ID: 25472471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.